Cutia Therapeutics Enrolls Final Patient in Phase II Trial of Weight Loss Drug
Cutia Therapeutics Enrolls Final Patient in Phase II Trial of Weight Loss Drug
Cutia Therapeutics在減肥藥物II期試驗中招募了最後一位患者
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊